2011
DOI: 10.1590/s0365-05962011000700029
|View full text |Cite
|
Sign up to set email alerts
|

Mixofibrossarcoma: relato de caso

Abstract: Myxofibrosarcoma, previously known as malignant fibrous histiocytoma, myxoid variant, is a rare tumor of mesenchymal origin, composed of spindle cells and myxoid stroma. It mainly affects elderly people, involving the lower extremities and frequently extending to the dermis and subcutaneous tissue. The tumor presents high rates of recurrence, and a deep biopsy is required to obtain the correct diagnosis. We report a case of high-grade mixofibrossarcoma characterized by a rapidly growing tumor and the presence … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
8
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 6 publications
0
8
0
Order By: Relevance
“…This peculiar characteristic makes it very important to represent the lesion adequately for histopathological examination. 2 , 6 …”
Section: Discussionmentioning
confidence: 99%
“…This peculiar characteristic makes it very important to represent the lesion adequately for histopathological examination. 2 , 6 …”
Section: Discussionmentioning
confidence: 99%
“…2 Undifferentiated pleomorphic sarcoma is a tumor whose histogenesis is not yet clearly defined. 1 We describe a case of undif- dermatofibrosarcoma protuberans, atypical fibroxanthoma, and leiomyosarcoma. 2 The extremities are the most common sites of involvement, especially the lower limbs.…”
mentioning
confidence: 98%
“…2 Undifferentiated pleomorphic sarcoma is a tumor whose histogenesis is not yet clearly defined. 1 We describe a case of undifferentiated pleomorphic sarcoma with cutaneous presentation and review some aspects of the disease, describing the main differential diagnoses and the clinical and histopathological findings of this rare tumor in its exuberant form, based on the current literature. We report the case of a 74-year-old male patient who sought treatment due to a rapid-onset skin lesion in the thoracic region after two months of Methotrexate is generally administered once weekly to patients, with doses ranging from 7.5 to 25 mg/week.…”
mentioning
confidence: 99%